Link Therapeutics Inc.
PrivateLast Round
Series B
Jul 18, 2025
Total Funding Raised
$7.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Link Therapeutics Inc. is a biotechnology company that develops therapeutic methods and medical devices for autoimmune diseases by targeting and removing pathogenic autoantibodies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Link Therapeutics Inc. Comparables
Compare Link Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Otsuka Holdings | 76% | |
| POCARD Ltd. | 73% | |
| Vitrosorb AB | 72% |
Link Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 18, 2025 | ||||
| Series A | Feb 28, 2023 | ||||
| Seed | Dec 22, 2022 |
Link Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ITOCHU Technology Ventures | Series B |
| Kobe University Capital | Series B |
| Mitsubishi UFJ Capital | Series B, Series A |
| Kyoto University Innovation Capital | Series B, Series A, Seed |
| SMBC Venture Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 381% MoM.
- May 20, 2026
Monthly visitors increased 33% MoM, reaching 1.1K.
Link Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Link Therapeutics Inc.'s valuation, stock price, and market status.
Is Link Therapeutics Inc. a public or private company?
Link Therapeutics Inc. is a private company.
What is the current stock price of Link Therapeutics Inc.?
Link Therapeutics Inc. is a private company, so its shares have no public market price. Caplight tracks Link Therapeutics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Link Therapeutics Inc. worth (valuation)?
Valuation information for Link Therapeutics Inc. is not publicly available.
Can I buy Link Therapeutics Inc. stock?
Link Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Link Therapeutics Inc.'s last funding round?
Link Therapeutics Inc.'s most recent funding round was Series B on July 18, 2025.
Who are the main investors in Link Therapeutics Inc.?
Key investors in Link Therapeutics Inc. include Kyoto University Innovation Capital.
Will Link Therapeutics Inc. IPO soon?
No public IPO plans have been announced for Link Therapeutics Inc..
How can I track Link Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Link Therapeutics Inc.'s shares on secondary markets.